The ICMRA collaborative hybrid inspection pilot (CHIP)
by Giuliana Miglierini Hybrid inspections emerged during the pandemic as a new way to approach the assessment of…
EC Communication (part 2): a Critical Medicines Alliance to support European pharma supply chain
by Giuliana Miglierini After last week’s examination of the first part of the Commission’s Communication, specifically targeted to…
EMA’s new Quality Innovation Expert Group (QIG)
by Giuliana Miglierini Innovative approaches to the development manufacturing and quality control of medicines are becoming the new…
ICMRA report on best practices against antimicrobial resistance
by Giuliana Miglierini Antimicrobial resistance (AMR) is the consequence of mutations that allow microbes to survive pharmacological treatment.…
Artificial intelligence in medicine regulation
The International Coalition of Medicines Regulatory Authorities (ICMRA) sets out recommendations to help regulators to address the challenges…